Kaken Pharmaceutical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Kaken Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 3 865 JPY -1.02%

Market Cap: ¥146.4B

K	Kaken Pharmaceutical Co Ltd TSE:4521	JP
D	DigitalOcean Holdings Inc XBER:0SU	US
C	CITIC Securities Co Ltd XMUN:CI9	CN
E	Esi SpA MIL:ESI	IT
V	V L Enterprise PCL SET:VL	TH
	Saranacentral Bajatama Tbk PT IDX:BAJA	ID
	Proact IT Group AB F:PIU0	SE
G	Gap Inc XMUN:GAP	US
	Equillium Inc NASDAQ:EQ	US
	Graphite One Inc XTSX:GPH	CA

Profitability Summary

Kaken Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

58%

Strong 3Y Average Gross Margin

57%

Gross Margin is Increasing

54% > 58%

Healthy Operating Margin

11%

Sustainable 3Y Average Operating Margin

12%

Operating Margin is Increasing

10% > 11%

Healthy Net Margin

12%

Low 3Y Average Net Margin

Net Margin is Increasing

7% > 12%

Negative Free Cash Flow Margin

-19%

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.